Abstract
INTRODUCTION
Morbid obesity is a multifactorial disease that is a major health problem all over the world. In this study, we presented the first two-year follow-up of patients who underwent conventional Roux En-Y Type Gastric Bypass (RYGB) performed in the years when obesity surgery has just begun in our country.
METHODS
In our study, pre-and post-operative data of 15 patients who underwent RGYB due to morbid obesity.
RESULTS
The data of 15 patients, 6 male (40%) and 9 female (60%), were evaluated in the study. The mean age of the patients was 38 ± 12.90 (24-63) years in all cases and 31.5 ± 8.16 (24-46) years in men and 42.33 ± 14.02 (26-63) years in women. In the preoperative evaluation of patients in terms of concomitant diseases, it was determined that 47% of the patients had HT (n = 7), 20% (n = 3) Type II DM, 6.67% (n = 1) hypermenorrhea, 6.67% (n = 1) venous ulcers in the lower extremity, 13.34% (n = 2) menstrual cycle irregularity, 6.67% (n = 1) UAS, 6.67% (n = 1) chronic obstructive pulmonary disease (COPD), 20% (n = 3) Hepatosteatosis.
DISCUSSION AND CONCLUSION
Conventional RYGB surgery is one of the first morbid obesity surgeries performed in our country. It is a safe method in the treatment of morbid obesity, which enables patients to lose weight and at the same time to recover from obesity induced by comorbid diseases, and causes a significant change in the quality of life of patients.
Keywords: Morbid obesity, conventional roux en-y gastric by-pass, obesity surgery, quality of life
